Global Preventable Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Preventable Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Preventable Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Preventable Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Preventable Vaccines Segment by Type

2.2.1 Adult Preventable Vaccines

2.2.2 Pediatric Preventable Vaccines

2.3 Preventable Vaccines Sales by Type

2.3.1 Global Preventable Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Preventable Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Preventable Vaccines Sale Price by Type (2017-2022)

2.4 Preventable Vaccines Segment by Application

2.4.1 Bacterial Diseases

2.4.2 Virus Diseases

2.5 Preventable Vaccines Sales by Application

2.5.1 Global Preventable Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Preventable Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Preventable Vaccines Sale Price by Application (2017-2022)

3 Global Preventable Vaccines by Company

3.1 Global Preventable Vaccines Breakdown Data by Company

3.1.1 Global Preventable Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Preventable Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Preventable Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Preventable Vaccines Revenue by Company (2020-2022)

3.2.2 Global Preventable Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Preventable Vaccines Sale Price by Company

3.4 Key Manufacturers Preventable Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Preventable Vaccines Product Location Distribution

3.4.2 Players Preventable Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Preventable Vaccines by Geographic Region

4.1 World Historic Preventable Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Preventable Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Preventable Vaccines Annual Revenue by Geographic Region

4.2 World Historic Preventable Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Preventable Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Preventable Vaccines Annual Revenue by Country/Region

4.3 Americas Preventable Vaccines Sales Growth

4.4 APAC Preventable Vaccines Sales Growth

4.5 Europe Preventable Vaccines Sales Growth

4.6 Middle East & Africa Preventable Vaccines Sales Growth

5 Americas

5.1 Americas Preventable Vaccines Sales by Country

5.1.1 Americas Preventable Vaccines Sales by Country (2017-2022)

5.1.2 Americas Preventable Vaccines Revenue by Country (2017-2022)

5.2 Americas Preventable Vaccines Sales by Type

5.3 Americas Preventable Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Preventable Vaccines Sales by Region

6.1.1 APAC Preventable Vaccines Sales by Region (2017-2022)

6.1.2 APAC Preventable Vaccines Revenue by Region (2017-2022)

6.2 APAC Preventable Vaccines Sales by Type

6.3 APAC Preventable Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Preventable Vaccines by Country

7.1.1 Europe Preventable Vaccines Sales by Country (2017-2022)

7.1.2 Europe Preventable Vaccines Revenue by Country (2017-2022)

7.2 Europe Preventable Vaccines Sales by Type

7.3 Europe Preventable Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Preventable Vaccines by Country

8.1.1 Middle East & Africa Preventable Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Preventable Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Preventable Vaccines Sales by Type

8.3 Middle East & Africa Preventable Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Preventable Vaccines

10.3 Manufacturing Process Analysis of Preventable Vaccines

10.4 Industry Chain Structure of Preventable Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Preventable Vaccines Distributors

11.3 Preventable Vaccines Customer

12 World Forecast Review for Preventable Vaccines by Geographic Region

12.1 Global Preventable Vaccines Market Size Forecast by Region

12.1.1 Global Preventable Vaccines Forecast by Region (2023-2028)

12.1.2 Global Preventable Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Preventable Vaccines Forecast by Type

12.7 Global Preventable Vaccines Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Preventable Vaccines Product Offered

13.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Preventable Vaccines Product Offered

13.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Preventable Vaccines Product Offered

13.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Preventable Vaccines Product Offered

13.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Preventable Vaccines Product Offered

13.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

13.6 Takeda Pharmaceutical

13.6.1 Takeda Pharmaceutical Company Information

13.6.2 Takeda Pharmaceutical Preventable Vaccines Product Offered

13.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Takeda Pharmaceutical Main Business Overview

13.6.5 Takeda Pharmaceutical Latest Developments

13.7 Abbott

13.7.1 Abbott Company Information

13.7.2 Abbott Preventable Vaccines Product Offered

13.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Abbott Main Business Overview

13.7.5 Abbott Latest Developments

13.8 Roche

13.8.1 Roche Company Information

13.8.2 Roche Preventable Vaccines Product Offered

13.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Roche Main Business Overview

13.8.5 Roche Latest Developments

13.9 AstraZeneca

13.9.1 AstraZeneca Company Information

13.9.2 AstraZeneca Preventable Vaccines Product Offered

13.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AstraZeneca Main Business Overview

13.9.5 AstraZeneca Latest Developments

13.10 Mitsubishi Tanabe Pharma

13.10.1 Mitsubishi Tanabe Pharma Company Information

13.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered

13.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mitsubishi Tanabe Pharma Main Business Overview

13.10.5 Mitsubishi Tanabe Pharma Latest Developments

13.11 Lupin

13.11.1 Lupin Company Information

13.11.2 Lupin Preventable Vaccines Product Offered

13.11.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Lupin Main Business Overview

13.11.5 Lupin Latest Developments

13.12 Serum Institute of India

13.12.1 Serum Institute of India Company Information

13.12.2 Serum Institute of India Preventable Vaccines Product Offered

13.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Serum Institute of India Main Business Overview

13.12.5 Serum Institute of India Latest Developments

13.13 LG Life Sciences

13.13.1 LG Life Sciences Company Information

13.13.2 LG Life Sciences Preventable Vaccines Product Offered

13.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 LG Life Sciences Main Business Overview

13.13.5 LG Life Sciences Latest Developments

13.14 S K Chemicals

13.14.1 S K Chemicals Company Information

13.14.2 S K Chemicals Preventable Vaccines Product Offered

13.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 S K Chemicals Main Business Overview

13.14.5 S K Chemicals Latest Developments

13.15 Shenzhen Kangtai Biological Products

13.15.1 Shenzhen Kangtai Biological Products Company Information

13.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered

13.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shenzhen Kangtai Biological Products Main Business Overview

13.15.5 Shenzhen Kangtai Biological Products Latest Developments

13.16 Sinovac Biotech

13.16.1 Sinovac Biotech Company Information

13.16.2 Sinovac Biotech Preventable Vaccines Product Offered

13.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sinovac Biotech Main Business Overview

13.16.5 Sinovac Biotech Latest Developments

13.17 Janssen Pharmaceuticals

13.17.1 Janssen Pharmaceuticals Company Information

13.17.2 Janssen Pharmaceuticals Preventable Vaccines Product Offered

13.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Janssen Pharmaceuticals Main Business Overview

13.17.5 Janssen Pharmaceuticals Latest Developments

13.18 Crucell

13.18.1 Crucell Company Information

13.18.2 Crucell Preventable Vaccines Product Offered

13.18.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Crucell Main Business Overview

13.18.5 Crucell Latest Developments

13.19 Bavarian Nordic

13.19.1 Bavarian Nordic Company Information

13.19.2 Bavarian Nordic Preventable Vaccines Product Offered

13.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Bavarian Nordic Main Business Overview

13.19.5 Bavarian Nordic Latest Developments

13.20 Baxter

13.20.1 Baxter Company Information

13.20.2 Baxter Preventable Vaccines Product Offered

13.20.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Baxter Main Business Overview

13.20.5 Baxter Latest Developments

13.21 Bharat Biotech

13.21.1 Bharat Biotech Company Information

13.21.2 Bharat Biotech Preventable Vaccines Product Offered

13.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Bharat Biotech Main Business Overview

13.21.5 Bharat Biotech Latest Developments

13.22 Dynavax

13.22.1 Dynavax Company Information

13.22.2 Dynavax Preventable Vaccines Product Offered

13.22.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Dynavax Main Business Overview

13.22.5 Dynavax Latest Developments

13.23 Bausch Health

13.23.1 Bausch Health Company Information

13.23.2 Bausch Health Preventable Vaccines Product Offered

13.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Bausch Health Main Business Overview

13.23.5 Bausch Health Latest Developments

13.24 Protein Sciences

13.24.1 Protein Sciences Company Information

13.24.2 Protein Sciences Preventable Vaccines Product Offered

13.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Protein Sciences Main Business Overview

13.24.5 Protein Sciences Latest Developments

13.25 Panacea Biotec

13.25.1 Panacea Biotec Company Information

13.25.2 Panacea Biotec Preventable Vaccines Product Offered

13.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Panacea Biotec Main Business Overview

13.25.5 Panacea Biotec Latest Developments

14 Research Findings and Conclusion

Table 1. Preventable Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Preventable Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Adult Preventable Vaccines

Table 4. Major Players of Pediatric Preventable Vaccines

Table 5. Global Preventable Vaccines Sales by Type (2017-2022) & (K Units)

Table 6. Global Preventable Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Preventable Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Preventable Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Preventable Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Preventable Vaccines Sales by Application (2017-2022) & (K Units)

Table 11. Global Preventable Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Preventable Vaccines Revenue by Application (2017-2022)

Table 13. Global Preventable Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Preventable Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Preventable Vaccines Sales by Company (2020-2022) & (K Units)

Table 16. Global Preventable Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Preventable Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Preventable Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Preventable Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Preventable Vaccines Producing Area Distribution and Sales Area

Table 21. Players Preventable Vaccines Products Offered

Table 22. Preventable Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Preventable Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Preventable Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Preventable Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Preventable Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Preventable Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Preventable Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Preventable Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Preventable Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Preventable Vaccines Sales by Country (2017-2022) & (K Units)

Table 34. Americas Preventable Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Preventable Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Preventable Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Preventable Vaccines Sales by Type (2017-2022) & (K Units)

Table 38. Americas Preventable Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Preventable Vaccines Sales by Application (2017-2022) & (K Units)

Table 40. Americas Preventable Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Preventable Vaccines Sales by Region (2017-2022) & (K Units)

Table 42. APAC Preventable Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Preventable Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Preventable Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Preventable Vaccines Sales by Type (2017-2022) & (K Units)

Table 46. APAC Preventable Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Preventable Vaccines Sales by Application (2017-2022) & (K Units)

Table 48. APAC Preventable Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Preventable Vaccines Sales by Country (2017-2022) & (K Units)

Table 50. Europe Preventable Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Preventable Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Preventable Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Preventable Vaccines Sales by Type (2017-2022) & (K Units)

Table 54. Europe Preventable Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Preventable Vaccines Sales by Application (2017-2022) & (K Units)

Table 56. Europe Preventable Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Preventable Vaccines Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Preventable Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Preventable Vaccines Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Preventable Vaccines Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Preventable Vaccines

Table 66. Key Market Challenges & Risks of Preventable Vaccines

Table 67. Key Industry Trends of Preventable Vaccines

Table 68. Preventable Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Preventable Vaccines Distributors List

Table 71. Preventable Vaccines Customer List

Table 72. Global Preventable Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Preventable Vaccines Sales Market Forecast by Region

Table 74. Global Preventable Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Preventable Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Preventable Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Preventable Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Preventable Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Preventable Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Preventable Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Preventable Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Preventable Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Preventable Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Preventable Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Preventable Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Preventable Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Preventable Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Preventable Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Preventable Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Preventable Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Preventable Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. GlaxoSmithKline Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. GlaxoSmithKline Preventable Vaccines Product Offered

Table 94. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. GlaxoSmithKline Main Business

Table 96. GlaxoSmithKline Latest Developments

Table 97. Merck Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Preventable Vaccines Product Offered

Table 99. Merck Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Novartis Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Novartis Preventable Vaccines Product Offered

Table 104. Novartis Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Novartis Main Business

Table 106. Novartis Latest Developments

Table 107. Pfizer Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer Preventable Vaccines Product Offered

Table 109. Pfizer Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer Main Business

Table 111. Pfizer Latest Developments

Table 112. Sanofi Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Sanofi Preventable Vaccines Product Offered

Table 114. Sanofi Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Sanofi Main Business

Table 116. Sanofi Latest Developments

Table 117. Takeda Pharmaceutical Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Takeda Pharmaceutical Preventable Vaccines Product Offered

Table 119. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Takeda Pharmaceutical Main Business

Table 121. Takeda Pharmaceutical Latest Developments

Table 122. Abbott Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Abbott Preventable Vaccines Product Offered

Table 124. Abbott Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Abbott Main Business

Table 126. Abbott Latest Developments

Table 127. Roche Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Roche Preventable Vaccines Product Offered

Table 129. Roche Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Roche Main Business

Table 131. Roche Latest Developments

Table 132. AstraZeneca Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. AstraZeneca Preventable Vaccines Product Offered

Table 134. AstraZeneca Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. AstraZeneca Main Business

Table 136. AstraZeneca Latest Developments

Table 137. Mitsubishi Tanabe Pharma Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered

Table 139. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Mitsubishi Tanabe Pharma Main Business

Table 141. Mitsubishi Tanabe Pharma Latest Developments

Table 142. Lupin Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Lupin Preventable Vaccines Product Offered

Table 144. Lupin Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Lupin Main Business

Table 146. Lupin Latest Developments

Table 147. Serum Institute of India Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Serum Institute of India Preventable Vaccines Product Offered

Table 149. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Serum Institute of India Main Business

Table 151. Serum Institute of India Latest Developments

Table 152. LG Life Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. LG Life Sciences Preventable Vaccines Product Offered

Table 154. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. LG Life Sciences Main Business

Table 156. LG Life Sciences Latest Developments

Table 157. S K Chemicals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. S K Chemicals Preventable Vaccines Product Offered

Table 159. S K Chemicals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. S K Chemicals Main Business

Table 161. S K Chemicals Latest Developments

Table 162. Shenzhen Kangtai Biological Products Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered

Table 164. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Shenzhen Kangtai Biological Products Main Business

Table 166. Shenzhen Kangtai Biological Products Latest Developments

Table 167. Sinovac Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Sinovac Biotech Preventable Vaccines Product Offered

Table 169. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Sinovac Biotech Main Business

Table 171. Sinovac Biotech Latest Developments

Table 172. Janssen Pharmaceuticals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. Janssen Pharmaceuticals Preventable Vaccines Product Offered

Table 174. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Janssen Pharmaceuticals Main Business

Table 176. Janssen Pharmaceuticals Latest Developments

Table 177. Crucell Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 178. Crucell Preventable Vaccines Product Offered

Table 179. Crucell Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Crucell Main Business

Table 181. Crucell Latest Developments

Table 182. Bavarian Nordic Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 183. Bavarian Nordic Preventable Vaccines Product Offered

Table 184. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Bavarian Nordic Main Business

Table 186. Bavarian Nordic Latest Developments

Table 187. Baxter Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 188. Baxter Preventable Vaccines Product Offered

Table 189. Baxter Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Baxter Main Business

Table 191. Baxter Latest Developments

Table 192. Bharat Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 193. Bharat Biotech Preventable Vaccines Product Offered

Table 194. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 195. Bharat Biotech Main Business

Table 196. Bharat Biotech Latest Developments

Table 197. Dynavax Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 198. Dynavax Preventable Vaccines Product Offered

Table 199. Dynavax Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 200. Dynavax Main Business

Table 201. Dynavax Latest Developments

Table 202. Bausch Health Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 203. Bausch Health Preventable Vaccines Product Offered

Table 204. Bausch Health Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 205. Bausch Health Main Business

Table 206. Bausch Health Latest Developments

Table 207. Protein Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 208. Protein Sciences Preventable Vaccines Product Offered

Table 209. Protein Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 210. Protein Sciences Main Business

Table 211. Protein Sciences Latest Developments

Table 212. Panacea Biotec Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 213. Panacea Biotec Preventable Vaccines Product Offered

Table 214. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 215. Panacea Biotec Main Business

Table 216. Panacea Biotec Latest Developments

List of Figures

Figure 1. Picture of Preventable Vaccines

Figure 2. Preventable Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Preventable Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Preventable Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Preventable Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Adult Preventable Vaccines

Figure 10. Product Picture of Pediatric Preventable Vaccines

Figure 11. Global Preventable Vaccines Sales Market Share by Type in 2021

Figure 12. Global Preventable Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Preventable Vaccines Consumed in Bacterial Diseases

Figure 14. Global Preventable Vaccines Market: Bacterial Diseases (2017-2022) & (K Units)

Figure 15. Preventable Vaccines Consumed in Virus Diseases

Figure 16. Global Preventable Vaccines Market: Virus Diseases (2017-2022) & (K Units)

Figure 17. Global Preventable Vaccines Sales Market Share by Application (2017-2022)

Figure 18. Global Preventable Vaccines Revenue Market Share by Application in 2021

Figure 19. Preventable Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Preventable Vaccines Revenue Market Share by Company in 2021

Figure 21. Global Preventable Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Preventable Vaccines Revenue Market Share by Geographic Region in 2021

Figure 23. Global Preventable Vaccines Sales Market Share by Region (2017-2022)

Figure 24. Global Preventable Vaccines Revenue Market Share by Country/Region in 2021

Figure 25. Americas Preventable Vaccines Sales 2017-2022 (K Units)

Figure 26. Americas Preventable Vaccines Revenue 2017-2022 ($ Millions)

Figure 27. APAC Preventable Vaccines Sales 2017-2022 (K Units)

Figure 28. APAC Preventable Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. Europe Preventable Vaccines Sales 2017-2022 (K Units)

Figure 30. Europe Preventable Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Preventable Vaccines Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Preventable Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Americas Preventable Vaccines Sales Market Share by Country in 2021

Figure 34. Americas Preventable Vaccines Revenue Market Share by Country in 2021

Figure 35. United States Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Preventable Vaccines Sales Market Share by Region in 2021

Figure 40. APAC Preventable Vaccines Revenue Market Share by Regions in 2021

Figure 41. China Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Preventable Vaccines Sales Market Share by Country in 2021

Figure 48. Europe Preventable Vaccines Revenue Market Share by Country in 2021

Figure 49. Germany Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Preventable Vaccines Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Preventable Vaccines Revenue Market Share by Country in 2021

Figure 56. Egypt Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Preventable Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Preventable Vaccines in 2021

Figure 62. Manufacturing Process Analysis of Preventable Vaccines

Figure 63. Industry Chain Structure of Preventable Vaccines

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles